Part A: Amendments to the Poisons Standard referred to an expert advisory committee
3. Advisory Committee on Chemicals Scheduling (ACCS #22)
3.1 Mefentrifluconazole
On this page: Delegate's final decision | Public submissions on the interim decision | Interim decision | Scheduling proposal
Delegate's final decision
The delegate's final decision under regulation 42ZCZR of the Therapeutic Goods Regulations 1990 (the Regulations) is to create a new Schedule 5 entry for mefentrifluconazole in the Poisons Standard as follows:
Schedule 5 - New Entry
MEFENTRIFLUCONAZOLE except in preparations containing 7.5 per cent or less of mefentrifluconazole.
Implementation date: 1 October 2018.
Reasons:
As no new evidence has been received to alter the interim decision for mefentrifluconazole, the delegate has confirmed that the final decision and reasons for the final decision are identical to the interim decision.
Public submissions on the interim decision
No public submissions were received before the second closing date in response to an invitation published on 7 June 2018 under regulation 42ZCKP of the Regulations.
Interim decision
The interim decision for mefentrifluconazole was published on the TGA website on 7 June 2018 at Publication of interim decisions amending, or not amending, the current Poisons Standard, June 2018 - 3.1 Mefentrifluconazole.
Scheduling proposal
The pre-meeting scheduling proposal for mefentrifluconazole was published on the TGA website on 21 December 2017 at Consultation: Proposed Amendments to the Poisons Standard - ACCS, ACMS and Joint ACCS-ACMS meetings, March 2018.